United States - English - NLM (National Library of Medicine)

bluepoint laboratories - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml - etoposide injection usp is indicated in the management of the following neoplasms: etoposide injection usp in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. etoposide injection usp in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. etoposide injection usp is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml - etoposide injection, usp is indicated in the management of the following neoplasms: etoposide injection in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. etoposide injection and/or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. etoposide is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.

United States - English - NLM (National Library of Medicine)

accord healthcare inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml - etoposide injection usp is indicated in the management of the following neoplasms: etoposide injection usp in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. etoposide injection usp in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. etoposide injection usp is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml - etoposide injection, usp is indicated in the management of the following neoplasms: etoposide injection, usp in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. adequate data on the use of etoposide capsules in the treatment of testicular cancer are not available. etoposide injection, usp and/or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. etoposide injection, usp is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.

United States - English - NLM (National Library of Medicine)

accord healthcare inc. - etoposide (unii: 6plq3cp4p3) (etoposide - unii:6plq3cp4p3) - etoposide 20 mg in 1 ml - etoposide injection usp is indicated in the management of the following neoplasms: etoposide injection usp in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. etoposide injection usp in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer. etoposide injection usp is contraindicated in patients who have demonstrated a previous hypersensitivity to etoposide or any component of the formulation.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - etoposide, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: ethanol; citric acid; polysorbate 80; macrogol 300; benzyl alcohol - small cell carcinoma of the lung. acute monocytic and myelomonocytic leukaemia; hodgkin's disease non-hodgkin's lymphoma.

Malta - English - Medicines Authority

fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents